(Q45976891)

English

Fluoxetine and cyclosporine in organ transplantation. Failure to detect significant drug interactions or adverse clinical events in depressed organ recipients.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

Fluoxetine and cyclosporine in organ transplantation. Failure to detect significant drug interactions or adverse clinical events in depressed organ recipients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

organ transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Strouse TB

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

Fairbanks LA

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

Skotzko CE

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

Fawzy FI

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

37

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

23-30

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

Psychiatric outcome of heart transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Depressive symptomatology and treatment in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropsychiatric assessment of liver transplantation candidates: delirium and other psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Organ transplant psychiatry: psychiatry's role in the second gift of life

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nortriptyline treatment of depressed cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychopharmacology and neuropsychiatric syndromes in organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychopharmacologic issues in organ transplantation. Part I: Pharmacokinetics in organ failure and psychiatric aspects of immunosuppressants and anti-infectious agents

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychopharmacologic issues in organ transplantation. Part 2: Psychopharmacologic medications

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic drug monitoring of cyclosporine.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoxetine disposition and elimination in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxic serotonin syndrome after fluoxetine plus carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular genetics of the debrisoquin-sparteine polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2896%2971594-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0033-3182(96)71594-3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/8600490

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45976891&oldid=1578328762"